← All stocks

enGene Therapeutics Inc.

ENGN Net buying

CIK 0001980845 #4240 in the set updated 22 Sep 2026

Bought (120 mo)

$8.07M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$787.98K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$787.98K

3 of 3 sales

Net

+$7.28M

+$7.28M against sales at will

By person

8 insiders · 20 transactions

0.1×

Ronald H.W. Cooper holds only 0.1 times base salary in stock. $89.00K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ronald H.W. Cooper last reported holding, valued at $8.90, the price Common Shares was last bought or sold at on the open market here, on 30 Oct 2024.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Forbion Growth Opportunities Fund I Cooperatief U.A. entity

10% owner

$8.01M (14)

—

+$8.01M

3,032,430

$26.99M

+51.6%

FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC

10% owner

—

$787.98K (3)

−$787.98K

3,036,153

$27.02M

−1.7%

Cooper Ronald Harold Wilfred

CEO & President

$57.00K (1)

—

+$57.00K

10,000

$89.00K

—

Forbion Growth Sponsor FEAC I B.V.

10% owner

—

3,765,932

$33.52M

+174.2%

BRUNK GERALD A

Director

—

238,851

$2.13M

—

Lumira Capital Investment Management Inc. entity

10% owner

—

238,851

$2.13M

—

CHEUNG ANTHONY TZEYEW

Chief Scientific Officer

—

102,873

$915.57K

—

Glickman Richard M

Director

—

24,675

$219.61K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Forbion Growth Opportunities Fund I Cooperatief U.A.

30 Oct 2024

10% owner

Buy

561,797

$8.90

$5.00M

Forbion Growth Opportunities Fund I Cooperatief U.A.

8 Oct 2024

10% owner

Buy

800

$6.60

$5.28K

Forbion Growth Opportunities Fund I Cooperatief U.A.

7 Oct 2024

10% owner

Buy

11,844

$6.55

$77.53K

Forbion Growth Opportunities Fund I Cooperatief U.A.

4 Oct 2024

10% owner

Buy

5,997

$6.54

$39.24K

Forbion Growth Opportunities Fund I Cooperatief U.A.

3 Oct 2024

10% owner

Buy

5,769

$6.48

$37.40K

Forbion Growth Opportunities Fund I Cooperatief U.A.

2 Oct 2024

10% owner

Buy

10,153

$6.37

$64.70K

Forbion Growth Opportunities Fund I Cooperatief U.A.

1 Oct 2024

10% owner

Buy

35,279

$6.44

$227.16K

Forbion Growth Opportunities Fund I Cooperatief U.A.

30 Sep 2024

10% owner

Buy

341,332

$6.34

$2.16M

Cooper Ronald Harold Wilfred

27 Sep 2024

Chief Executive Officer

Buy

10,000

$5.70

$57.00K

Forbion Growth Opportunities Fund I Cooperatief U.A.

27 Sep 2024

10% owner

Buy

3,243

$6.38

$20.69K

Forbion Growth Opportunities Fund I Cooperatief U.A.

27 Sep 2024

10% owner

Buy

38,396

$5.94

$228.01K

Forbion Growth Opportunities Fund I Cooperatief U.A.

29 Dec 2023

10% owner

Buy

9,620

$9.09

$87.45K

Forbion Growth Opportunities Fund I Cooperatief U.A.

29 Dec 2023

10% owner

Buy

400

$8.30

$3.32K

Forbion Growth Opportunities Fund I Cooperatief U.A.

28 Dec 2023

10% owner

Buy

5,050

$7.69

$38.83K

Forbion Growth Opportunities Fund I Cooperatief U.A.

27 Dec 2023

10% owner

Buy

2,750

$7.17

$19.71K

Show all 20 transactions →

enGene Therapeutics Inc.

By person

Individual transactions

What was left out